Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,930 | -46,339 | -29,702 | -28,210 | -22,028 |
| Depreciation Amortization | 457 | 206 | 209 | 177 | 162 |
| Accounts receivable | -51,791 | N/A | 42 | -44 | -3 |
| Accounts payable and accrued liabilities | -2,560 | 2,078 | -7 | 1,082 | 103 |
| Other Working Capital | -39,408 | 2,230 | 1,066 | 1,835 | -2,646 |
| Other Operating Activity | 60,616 | 3,416 | 4,034 | 4,005 | 2,444 |
| Operating Cash Flow | $-50,615 | $-38,410 | $-24,357 | $-21,155 | $-21,968 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,346 | -16,734 | -3,490 | -7,710 | 7,539 |
| PPE Investments | -116 | -327 | -219 | -1,425 | -113 |
| Investing Cash Flow | $21,231 | $-17,062 | $-3,709 | $-9,135 | $7,426 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,606 | 56,115 | 17,898 | 41,593 | 40,100 |
| Other Financing Activity | -287 | -199 | 0 | 165 | 0 |
| Financing Cash Flow | $26,319 | $55,917 | $17,898 | $41,758 | $40,100 |
| Exchange Rate Effect | -2 | 3 | -9 | -13 | 13 |
| Beginning Cash Position | 43,823 | 43,375 | 53,551 | 42,097 | 16,525 |
| End Cash Position | 40,756 | 43,823 | 43,375 | 53,551 | 42,097 |
| Net Cash Flow | $-3,067 | $448 | $-10,177 | $11,455 | $25,572 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,615 | -38,410 | -24,357 | -21,155 | -21,968 |
| Capital Expenditure | -116 | -327 | -219 | -1,425 | -113 |
| Free Cash Flow | -50,730 | -38,737 | -24,576 | -22,581 | -22,080 |